OTCMKTS:TPIY Tianyin Pharmaceutical (TPIY) Stock Price, News & Analysis → Beta testers blew this thing up (From Prosper Trading Academy) (Ad) Free TPIY Stock Alerts $0.0001 +0.00 (+∞) (As of 07/15/2019) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0178Volume88,900 shsAverage Volume36,100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tianyin Pharmaceutical alerts: Email Address Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> About Tianyin Pharmaceutical Stock (OTCMKTS:TPIY)Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.Read More TPIY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TPIY Stock News HeadlinesMarch 17, 2023 | wsj.comTasly Pharmaceutical Group Co. Ltd. AMarch 2, 2023 | uk.investing.comTianjin Chase Sun Pharmaceutical Co Ltd (300026)February 28, 2023 | wsj.comTianjin Chase Sun Pharmaceutical Co. Ltd.February 25, 2023 | seekingalpha.comArrowhead Pharmaceuticals Requires CautionFebruary 23, 2023 | uk.finance.yahoo.comA Look At The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)February 23, 2023 | wsj.comTianjin Tianyao Pharmaceutical Co. Ltd.February 22, 2023 | morningstar.comTianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class SFebruary 18, 2023 | marketwatch.comRifampicin Market Analysis by Application like Tuberculosis, Leprosy, Legionnaire's Disease, Others)February 9, 2023 | marketwatch.comPermethrin Spray Market to Grow Exponentially Due to Rising DemandFebruary 8, 2023 | marketwatch.comDoxofylline Tablets Market is set to see Revolutionary growth in decadeFebruary 8, 2023 | marketwatch.comDactinomycin Market is anticipated to boost sales at a Impressive CAGRFebruary 1, 2023 | marketwatch.comCyclopentanone (Cas 120-92-3) Market : Future Growth with Technology and Current Trends 2023 to 2029January 23, 2023 | marketwatch.comMycophenolic Acid Market 2023 : Profiling Key Players, Value Estimation and Analysis by Recent Trends to 2028January 20, 2023 | marketwatch.comDibucaine(Cinchocaine) API Market Size, Share, Growth, Revenue, Demand, Future Potential, and Forecast from 2023 to 2029January 12, 2023 | msn.comSix types of Benylin and Nurofen for children among medicines in short supplySee More Headlines Receive TPIY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tianyin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:TPIY Previous SymbolNYSEMKT:TPI CUSIPN/A CIK1362718 Webwww.tianyinpharma.com Phone00-86-028-8551-6696FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta54.39 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesGuo Qing JiangChairman, President & Chief Executive OfficerTao YangChief Operating OfficerLi Ying WangFinancial ControllerYing ZhangDirector-Human ResourcesKey CompetitorsAbliva AB (publ)OTCMKTS:NEVPFAcusphereOTCMKTS:ACUSAddex TherapeuticsOTCMKTS:ADDXFAeolus PharmaceuticalsOTCMKTS:AOLSAffymaxOTCMKTS:AFFYView All Competitors TPIY Stock Analysis - Frequently Asked Questions How have TPIY shares performed in 2024? Tianyin Pharmaceutical's stock was trading at $0.0001 on January 1st, 2024. Since then, TPIY stock has increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here. What other stocks do shareholders of Tianyin Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tianyin Pharmaceutical investors own include International Business Machines (IBM). How do I buy shares of Tianyin Pharmaceutical? Shares of TPIY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TPIY) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tianyin Pharmaceutical Inc Co Please log in to your account or sign up in order to add this asset to your watchlist. Share Tianyin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.